Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.780
-0.070 (-3.78%)
At close: Jun 20, 2025, 4:00 PM
1.850
+0.070 (3.93%)
After-hours: Jun 20, 2025, 7:46 PM EDT
Intelligent Bio Solutions Employees
Intelligent Bio Solutions had 50 employees as of June 30, 2024. The number of employees decreased by 1 or -1.96% compared to the previous year.
Employees
50
Change (1Y)
-1
Growth (1Y)
-1.96%
Revenue / Employee
$58,729
Profits / Employee
-$205,258
Market Cap
12.30M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
INBS News
- 2 days ago - Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion - GlobeNewsWire
- 9 days ago - Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - GlobeNewsWire